|

161Tb RAD402 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Radiopharm Theranostics, Ltd1

Indications

  • Castration-resistant Prostate Cancer1
  • Cancer1

Other1 trial

A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.